In Gram-negative bacteria, envelope stress signals such as unfolded outer membrane proteins (OMP) activate the periplasmic protease DegS. This protease then triggers a cellular pathway to alleviate the stress. Now Sohn et al. (2007) show conclusively that inhibition of DegS is relieved allosterically by binding of the C-terminal sequences in unfolded OMPs to the PDZ domain of DegS.
The envelope of Gram-negative bacteria consists of the inner cytoplasmic membrane, the outer membrane, and the periplasmic space in between. Survival of these bacteria depends on the integrity of the envelope. The Gram-negative bacterium Escherichia coli has developed elaborate mechanisms to monitor and respond to specific forms of periplasmic stress signals (Alba and Gross, 2004; Ruiz and Silhavy, 2005) . In response to accumulation of unfolded or misfolded outer membrane proteins (OMPs) in the periplasm, a cascade of controlled proteolysis ensues, culminating in the transcriptional activation of genes that encode chaperones and proteases destined for the periplasm (Figure 1 ). In this issue, Sohn et al. (2007) report the mechanism of activation of the serine protease DegS, the sensor and first essential component of the OMP stress response.
DegS has a C-terminal PDZ domain that is exposed to the periplasm and an N-terminal transmembrane region that anchors DegS to the cytoplasmic membrane ( Figure 1 Recent investigations have markedly improved our understanding of the molecular underpinnings of the OMP stress response. For example, the C-terminal Tyr-X-Phe (YXF, where X is any amino acid) sequences of OMP were shown to bind directly to the PDZ domain of DegS, which triggers the activation of DegS and cleavage of RseA (Walsh et al., 2003) . However, how binding of the PDZ domain by the OMP peptides results in DegS activation is still under debate.
Compared to wild-type DegS, the DegS mutant lacking the PDZ domain exhibited lower expression levels yet displayed markedly higher σ E activity in E. coli, suggesting increased protease activity (Walsh et al., 2003) and a negative regulatory role for the PDZ domain. Supporting this notion, peptides with C-terminal OMP sequences were shown to directly bind to the PDZ domain of DegS in vitro and induced σ E activity in cells (Walsh et al., 2003) . These experiments suggest an allosteric model, in which binding of the OMP peptides to the PDZ domain relieves its inhibition of the protease domain.
The allosteric model was consistent with most of the experimental evidence. For example, the crystal structure of the ligand-free DegS revealed an unproductive active site conformation (Wilken et al., 2004; Zeth, 2004) . Binding of a decapeptide ending with the Tyr-Gln-Phe (YQF) sequence to the PDZ domain caused major conformational changes in the protease domain. Interestingly, the penultimate residue glutamine (Gln) donates a hydrogen bond to a main chain carbonyl group in the protease domain; this interaction was thought to pull a flexible L3 loop by 15 Å resulting in the formation of a productive conformation at the active site (Wilken et al., 2004) . On the basis of this observation, Wilken and colleagues proposed a "scaffold model" in which binding of the YQF motif by the PDZ domain was thought to orient the penultimate residue for interactions with residues in the protease domain, and such interactions were consequently responsible for the activation of DegS (Wilken et al., 2004 ). The scaffold model and the allosteric model are different and give rise to predictions that can be readily tested by experiments.
In their new work, Sohn et al. (2007) present a combination of biochemical and structural experiments that strongly support the allosteric model. Evaluation of the two competing models requires a sensitive protease assay for DegS. However, the previously reported DegS protease assays, involving incubation times of as much as 12 hr, were inadequate for determination of kinetic parameters that can definitively differentiate these two models. Optimization of the assay conditions shortened the time of cleavage reaction from hours to minutes (Sohn et al., 2007) . For the first time, the measured turnover rate of RseA cleavage by DegS in vitro was fast enough to account for the precipitous drop in intracellular RseA levels within minutes of OMP stress signaling. Importantly, under these conditions, initial rates of cleavage were linearly proportional to concentrations of DegS.
Steady-state kinetic parameters were found to be similar for DegS bound to OMP peptides and for a DegS variant lacking the PDZ domain (Sohn et al., 2007) . These observations demonstrate that neither PDZ nor the OMP peptide is required for efficient cleavage of RseA in vitro. This analysis supports the allosteric model and is inconsistent with the scaffold model, as the latter would predict a markedly lower turnover rate for the PDZ-deleted DegS variant. A direct test of the scaffold model is to assess the impact of the penultimate residue of OMP peptides on DegS protease activity. Compared to Gln or Tyr, placement of small and negatively charged amino acids, such as Ala and Asp, in the penultimate position in OMP peptides had little impact on the maximum cleavage activity of DegS (Sohn et al., 2007) . The concentrations of the various OMP peptides required for half-maximal activity of DegS correlated with their binding affinities. These data strongly argue against a critical role for the identity of the penultimate residue in OMP peptides as proposed by the scaffold model (Wilken et al., 2004) . Corroborating the biochemical analyses, structures of the PDZ-deleted DegS variants revealed an active site that more closely resembles the productive conformation (Sohn et al., 2007) .
These biochemical and structural data lend conclusive support to the allosteric model of DegS activation. The key question then becomes: What about the reported evidence that was thought to support the scaffold model? The experimental observation that gave rise to the scaffold model is a hydrogen bond between the penultimate Gln residue of the OMP peptide and a main chain group in the protease domain of DegS (Wilken et al., 2004) . However, the anticipated interaction between the antepenultimate Tyr residue of the OMP peptide YXF and the PDZ domain of DegS was not observed in the crystal structure (Wilken et al., 2004) . This observation contrasts sharply with the important role of the antepenultimate Tyr residue in OMP peptides (Walsh et al., 2003) and begs for cautious interpretation of any role for the penultimate residue Gln. After all, the YQF peptide was far less able to activate DegS compared to OMP peptides with hydrophobic amino acids in the penultimate position (Walsh et al., 2003; Wilken et al., 2004) .
The new study reveals additional mechanistic insights into DegS activity. Analysis of the Michaelis-Menten plot revealed a Hill constant indicative of cooperative RseA binding and cleavage by the DegS trimer (Sohn et al., 2007) . The Hill constants were similar for the intact DegS and PDZ-deleted DegS, suggesting that allostery from binding by OMP peptides is not responsible for the cooperativity of substrate cleavage. Additional analysis using an altered substrate, which slowed down cleavage, supports the hypothesis that the cooperativity may be derived from interactions among the RseA substrate molecules (Sohn et al., 2007) .
PDZ-mediated inhibition of DegS protease activity obviously depends on the interactions between PDZ and the protease domains. But which interactions and what amino acids? Mutagenesis of amino acids at the interface between PDZ and the protease domains revealed some tantalizing clues. Three amino acids (Lys243, Arg256, and Asp320) in the PDZ domain were found to be particularly important, as their mutation led to drastically increased basal rate cleavage of RseA (Sohn et al., 2007) . In addition, Arg178 in the protease domain, which is highly conserved among DegS orthologs, was thought to be the key determinant in the allosteric switch from the inactive to active conformation.
These latest advances contribute to an improved model ( Figure 1 ) and make quantitative understanding of the OMP stress response possible. For example, the moderate binding affinities between the OMP peptides and DegS likely ensure a threshold for detection of the stress response: only when there is an accumulation of the unfolded OMP proteins. In addition, the wide range of binding affinities for DegS-4.6 µM for the YYF sequence and 130 µM for the YAF sequence (Sohn et al., 2007) -may set a different threshold for the accumulation of differing OMP proteins. It should be noted, however, that many unanswered questions remain. RseB, a periplasmic protein that binds to RseA, was shown to inhibit DegS-mediated cleavage of RseA in vitro regardless of the OMP peptides (Cezairliyan and Sauer, 2007) . The molecular basis for this inhibition remains to be investigated. How DegS overcomes RseB-mediated inhibition of RseA during the OMP stress response remains unclear. Periplasmic proteolysis of RseA by DegS is merely a prerequisite for the second cleavage of RseA by the membrane-embedded metalloprotease YaeL-why this is the case remains unknown.
DegS is a representative member of a family of PDZ-containing serine proteases (Clausen et al., 2002) . Does the allosteric mechanism observed for DegS apply to other family members? After all, these proteases share conserved domain structures and sequences and form trimers in solution. Similar to DegS, deletion of the PDZ domain makes human HtrA2 (a DegS homolog) more active (Li et al., 2002) . Therefore, it is tempting to speculate that the mechanism of activation described by Sohn et al. might be generally applicable to other members of this family of proteases.
Vascular endothelial growth factor (VEGF) plays an indispensable role in the formation of new blood vessels in both physiological and pathological settings. The anti-VEGF monoclonal antibody bevacizumab (referred to henceforth as αVEGF), when used as the sole therapy in phase III clinical trials, has yet to produce improvements in overall survival rates for cancer patients. On the other hand, addition of αVEGF to αPlGF: A new Kid on the Antiangiogenesis Block Rakesh K. Jain 1, * and Lei Xu 1
